GENETIC ENGINEERING OF HUMAN PROLACTINOMA CELL LINES FOR DIABETES CELL THERAPY
- 2 Anni 1999/2001
- 103.291€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- ACTA DIABETOLOGICA
Secretory defects induced by immunosuppressive agents on human pancreatic β-cells
- CELL TRANSPLANTATION
Islet transplantation under the kidney capsule corrects the defects in glycogen metabolism in both liver and muscle of streptozocin-diabetic rats
- CELL TRANSPLANTATION
Effects of carboxypeptidase E overexpression on insulin mRNA levels, regulated insulin secretion, and proinsulin processing of pituitary GH3 cells transfected with a furin-cleavable human proinsulin cDNA
